-
News
News
Meet us at DCAT!
DELPHARM SECURES MAJOR QUÉBEC GOVERNMENT SUPPORT TO MODERNIZE ITS BOUCHERVILLE FACILITY
Delpharm is proud to announce a major milestone in the modernization of its Boucherville facility, made possible by a $60 million (…)
Investment in a new sterile filling line
Delpharm invests in its Saint-Rémy site to support its customer’s aseptic vials growth.
Quality of life at work at Delpharm
At Delpharm, quality of life at work is more than just a concept, it’s a daily commitment.
To mark this special week, our Chief Human (…)
Discover our 2025 CSR report
Read our CSR report to find out more about Delpharm’s strategy, commitments and actions.
Delpharm invests heavily in its Boucherville site
Find out how Delpharm will modernise its facilities at its Boucherville site and ensure the continued manufacture of sterile injectable (…)
Discover the Delpharm Excellence System
Delpharm’s operational excellence programme to provide industrial solutions tailored to the unique needs of each customer.
Delpharm secures corticoids manufacturing in France
Delpharm has inaugurated a new packaging line at its Lille site to improve the availability of corticoids for French patients
Discover our 2024 CSR report
Read our CSR report to find out more about Delpharm’s strategy, commitments and actions.
DISCOVER OUR ANALYTICAL EXPERTISE ON STRUCTURE ELUCIDATION AND IMPURITY ANALYSIS
A new state of the art technology to better understand your drug substance and drug product is now available at Delpharm Development Leiden
Delpharm continues its growth in Europe with the acquisition of state-of-the-art drug production facilities in the Netherlands, from Astellas
World-leading CDMO Delpharm expands its pharmaceutical network with the acquisition from Astellas of the Meppel pharmaceutical (…)
DELPHARM EXPERTISE IN MICROSPHERES
Delpharm is able to support your microsphere projects with development from scratch to commercial manufacturing through IMP (…)
Case study : How Delpharm serves HMNC Brain Health in its phase II clinical trial
Hand in hand collaboration and team spirit between each partner leads to a successful projects : making clinical batches available in a (…)
Prefilled syringe overview
Delpharm differentiates itself and adapts to the current and future needs of its customers with prefilled syringe dosage form.
Delpharm acquires an injectable drug development centre
Delpharm expands its pharmaceutical development services with the acquisition of an injectable drug development centre in the Netherlands.